Amgen Inc (NASDAQ:AMGN)
| 219.09 BATS BZX Real-Time Price As of 12:04pm ET |  -1.62 / -0.73%Today’s Change | 211.71 Today|||52-Week Range 296.67 | -16.58% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Bradway Robert A Chairman, President & Chief Executive Officer |  Sale | 3/17/2023 | 13,971 | $234.57 | $3.3M | -3.93% |
Eckert Robert A Director | Sale | 8/10/2022 | 6,791 | $252.09 | $1.7M | -12.43% |
Eckert Robert A Director |  Buy | 8/10/2022 | 20,000 | $85.59 | $1.7M | -12.43% |
Eckert Robert A Director | Sale | 8/18/2022 | 6,600 | $249.00 | $1.6M | -11.59% |
Gordon Murdo J /rwj/ EVP-Global Commercial Operations | Sale | 3/17/2023 | 3,978 | $234.57 | $933.1K | -3.93% |
Reese David M /amgen/ EVP-Research & Development | Sale | 3/17/2023 | 3,978 | $234.57 | $933.1K | -3.93% |
Santos Esteban EVP-Operations | Sale | 3/17/2023 | 3,881 | $234.57 | $910.4K | -3.93% |
Graham Jonathan P | Sale | 3/17/2023 | 3,785 | $234.57 | $887.8K | -3.93% |
Griffith Peter H Chief Financial Officer & Executive Vice President | Sale | 11/01/2022 | 3,030 | $270.35 | $819.2K | -18.86% |
Griffith Peter H Chief Financial Officer & Executive Vice President | Sale | 3/17/2023 | 3,403 | $234.57 | $798.2K | -3.93% |
Page of 9